Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/03/024122
CTRI/2020/03/024122
Not yet recruiting
未知

A Randomised controlled trial on inhaled Isopropyl alcohol versus orally disintegrating Ondansetron in the treatment of nausea and/or vomiting in Emergency Department

Mohanapriya V S0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K929- Disease of digestive system, unspecified

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K929- Disease of digestive system, unspecified
Sponsor
Mohanapriya V S
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Mohanapriya V S

Eligibility Criteria

Inclusion Criteria

  • •All patients who are hemodynamically stable, aged 18 and above, with complaints of nausea and/or vomiting, with severity of 3 or more in Verbal Numeric Response Scale (VNRS).

Exclusion Criteria

  • •Patient not willing to participate in the study
  • •Age less than 18 years
  • •Pregnant patients
  • •Patients using antiemetic prior to presentation
  • •Inability to inhale through nares
  • •Allergic to inhaled isopropyl alcohol or ondansetron
  • •Administration of drugs contraindicating alcohol administration
  • •Patients with history of intestinal obstruction, carcinoma or hemoptysis
  • •Patients with hemodynamic instability
  • •Patients with smell of alcohol in their breath

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Inhalation of heated, humidified air (rhinothermy) in the common cold: a feasibility studyCommon coldInfection - Other infectious diseases
ACTRN12616000470493Fisher & Paykel Healthcare30
Completed
Phase 2
Inhaled furosemide for dyspnoea relief in advanced heart failure
ISRCTN14593637niversity of Oxford40
Completed
Phase 2
Effect of inhaled pharmaceutical Penthrox (Methoxyflurane) on pain of limb fractureCondition 1: Sequelae of fracture of arm. Condition 2: Sequelae of other fractures of lower limb.Sequelae of injury classifiable to S42.-, S52.- and T10Sequelae of injury classifiable to S82.-, S92.- and T12
IRCT2015111724799N3Vice chancellor for research, Baqiyatallah University of Medical Sciences100
Completed
Phase 2
A randomized controlled trial on the use of Nitrous oxide versus conventional intravenous pain relief in minor gynecological proceduresanalgesic efficacy of the patient controlled inhaled Nitrous oxide with intravenous opioids (Pethidine &ampMidazolam) in reducing pain during minor gynecological operative procedure, including MVA, fractional curettage and dilatation and curettageNitrous oxide, Manual vacuum aspiration, Dilatation and curettage, Midazolam, Pethidine
TCTR20230107003Endowment fund, Faculty of Medicine, Chiang Mai University106
Active, not recruiting
Phase 1
A clinical trial into the relief of breathlessness in patients with heart failure by inhaling furosemide which is usually taken as a tablet or injection.Advanced heart failure with reduced ejection fraction (less than or equal to 40%) with significant breathlessness that limits what they are able to do. MRC Dyspnoea Scale =2.MedDRA version: 20.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849Therapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
EUCTR2017-000124-95-GBniversity of Oxford30